Izotropic Corporation completed a private placement financing, issuing 750,000 units at $0.20 each, raising $150,000. Each unit includes one common share and one warrant to buy an additional share at $0.30 within three years. The funds will support general working capital for the company, which is developing IzoView, a breast CT imaging system aimed at improving breast cancer screening and diagnosis. The securities are subject to regulatory approvals and a hold period before sale.
Izotropic Corporation's private placement news is context for readers following health-related companies. For readers following health stocks, here is Pluang's market snapshot as of Oct 06, 2026 18:43 WIB: Of 100 priced health-sector US stocks tradable on Pluang, 68 rose and 24 fell today. Notable movers include DNA at USD 15.30 (+2.14%), BBIO at USD 67.55 (+2.13%), and AZN at USD 159.68 (+2.01%).
Morgan Stanley analyst Bob Huang lowered American International Group's (AIG) price target to $80 from $81, with the stock trading around $76, indicating potential upside. AIG is set to report its Q3 2026 earnings on November 3, with investors focuse...
Vertiv Holdings, a maker of power and cooling equipment for data centers, faces mixed analyst opinions with GLJ Research rating it a "Sell" and BMO Capital giving an "Outperform" rating. Despite a recent stock pullback, the company reported a 241% in...
Apogee Enterprises reported strong fiscal Q2 results with adjusted earnings of $1.17 per share, nearly double the estimated $0.59, and revenue of $391.14 million, surpassing expectations of $362.6 million. This marks a continued trend of beating esti...
McKesson received a bullish price target of $977 from Morgan Stanley, suggesting a 6.7% upside from its current price of $915.45. The company agreed to acquire Option Care Health for $32.05 per share, valuing the deal at approximately $5.8 billion in...
Ameriprise Financial has authorized an additional $5.5 billion for share repurchases through September 2028, supported by $2.1 billion in excess capital and $2.8 billion in liquidity. The company returned $1.9 billion to shareholders in H1 2026, incl...
